Calvo, Andrea
Torrente, Miguel Angel
Görlinger, Klaus
Fernandez, Javier
Reverter, Enric
Vidal, Julia
Tassies, Dolors
Colmenero, Jordi
Blasi, Annabel
Reverter, Juan Carlos
Article History
Received: 8 June 2022
Accepted: 5 December 2022
First Online: 13 December 2022
Declarations
:
: This study was approved by the Ethics Committee of the Hospital Clinic of Barcelona (approval number HCB/2017/0948) on April 4<sup>th</sup>, 2018. Healthy individuals and patients were enrolled after giving written informed consent.
: Not applicable
: Klaus Görlinger is the medical director of TEM innovations gmbh, Munich, Germany. The others authors declare they have no competing interests.